ES2181667T3 - Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular. - Google Patents

Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.

Info

Publication number
ES2181667T3
ES2181667T3 ES91904077T ES91904077T ES2181667T3 ES 2181667 T3 ES2181667 T3 ES 2181667T3 ES 91904077 T ES91904077 T ES 91904077T ES 91904077 T ES91904077 T ES 91904077T ES 2181667 T3 ES2181667 T3 ES 2181667T3
Authority
ES
Spain
Prior art keywords
procedure
agents
proliferation
diagnosis
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91904077T
Other languages
English (en)
Spanish (es)
Inventor
Christian Brechot
Jian Wang
Xavier Chenivesse
Berthold Henglein
Frederique Zindy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2181667T3 publication Critical patent/ES2181667T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES91904077T 1990-02-12 1991-02-06 Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular. Expired - Lifetime ES2181667T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9001596A FR2658204A1 (fr) 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.

Publications (1)

Publication Number Publication Date
ES2181667T3 true ES2181667T3 (es) 2003-03-01

Family

ID=9393594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91904077T Expired - Lifetime ES2181667T3 (es) 1990-02-12 1991-02-06 Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.

Country Status (7)

Country Link
US (2) US5849508A (https=)
EP (1) EP0471804B1 (https=)
AT (1) ATE220717T1 (https=)
DE (1) DE69133067T2 (https=)
ES (1) ES2181667T3 (https=)
FR (1) FR2658204A1 (https=)
WO (1) WO1991012324A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
FR2712301A1 (fr) * 1993-11-10 1995-05-19 Inst Nat Sante Rech Med Séquence nucléotidique du promoteur de la cycline A humaine et séquences anti-sens y relatives.
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
WO2004040314A1 (en) * 2002-10-31 2004-05-13 Chemometec A/S A method for assessment of particles
WO2006119435A2 (en) * 2005-05-04 2006-11-09 Invitrogen Corporation Identification of cancer biomarkers and phosphorylated proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
EP0321362B1 (en) * 1987-12-16 1996-09-25 Institut Pasteur Retinoic acid receptor and derivatives thereof, DNA encoding either substance and use of the proteins and of the DNA

Also Published As

Publication number Publication date
EP0471804B1 (fr) 2002-07-17
US6103887A (en) 2000-08-15
FR2658204B1 (https=) 1994-08-19
ATE220717T1 (de) 2002-08-15
DE69133067D1 (de) 2002-08-22
WO1991012324A1 (fr) 1991-08-22
FR2658204A1 (fr) 1991-08-16
DE69133067T2 (de) 2003-05-08
US5849508A (en) 1998-12-15
EP0471804A1 (fr) 1992-02-26

Similar Documents

Publication Publication Date Title
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
DE3277801D1 (en) Use of 4-aminosalicylic acid as an anti-inflammatory agent
IT7823672A0 (it) Derivati di idantoina ad azione terapeutica e relativo procedimento di preparazione.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
IT8024545A0 (it) Composizioni farmaceutiche topiche contenenti trietilenetetramina eloro metodi di impiego.
IT8025206A0 (it) Derivati di 4-fenil-ftalazine ad azione terapeutica.
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
IT1064132B (it) Composizione per la determinazione di reattivita di tipo biologico e relativo procedimento di impiego
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
ES2173948T3 (es) Mezclas de 2',3'-didesoxi-inosina e hidrocarbamida para la inhibicion de la propagacion retroviral.
DK519387D0 (da) Farmaceutiske praeparater indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele samt anvendelse deraf
IT1148801B (it) Derivati del nor-tropano, loro procedimento di preparazione e loro applicazione terapeutica
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
ES2040137T3 (es) Agente para la tincion del pelo y su empleo.
ES447525A1 (es) Procedimiento para preparar 1-aril-2(1 imidazolil) alquil- eteres y tioeteres.
ES2139596T3 (es) Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.
ES2181667T3 (es) Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.
BG31498A3 (en) Method for obtaining of pyridiliminomethyl benzene derivatives
ES2058282T3 (es) Derivados de fenol, su produccion y uso.
IT7826173A0 (it) Nuovi derivati esteri del vincamino lo e procedimento per la loro preparazione.
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни